Price increases for generic medications inquiry

Inquiry by the Public Accounts Committee, 14 June 2018 to 14 June 2018. Its page on the Parliament website.

Reports and responses

• 62nd Report - Price increases for generic medications (12 October 2018)
• Treasury Minutes on the Government response to the Committee of Public Accounts on the Fifty-Ninth to the Sixty-Third reports from Session 2017-19 (10 January 2019)

Evidence sessions

• 4 July 2018: Mark Burdon, Regional Representative, North East and Cumbria, Pharmaceutical Services Negotiating Committee, Warwick Smith, Director General, British Association of Generic Manufacturers, and Professor Karim Meeran, Deputy Director of Medical Education, Imperial College; Sir Chris Wormald, Permanent Secretary, Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care, Dr Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England, and Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency (at 3.15pm).